<DOC>
	<DOCNO>NCT01274767</DOCNO>
	<brief_summary>Low-dose aspirin mainstay treatment patient coronary heart disease stroke . However , low-dose aspirin increase risk ulcer bleeding . Current evidence indicate 80 - 100 mg aspirin daily provide good protection vascular event risk ulcer bleed low ( 1 % per year ) . Since overall risk bleeding low , aspirin user previous ulcer disease require prophylaxis anti-ulcer drug . In contrast , aspirin user history ulcer disease 2- 4-fold increase risk ulcer bleeding . The best strategy reduce risk bleed high-risk aspirin user remain unclear . Current strategy high-risk patient include use anti-ulcer drug , elimination risk factor ( e.g . Helicobacter pylorus ) , use enteric-coated aspirin . Although co-therapy aspirin acid suppressant reduces risk ulcer bleeding , drug compliance may limit clinical usefulness particularly patient already receive multiple drug . The efficacy enteric-coated aspirin prevent ulcer complication show conflict result . One study find enteric-coated aspirin increase risk ulcer bleeding . A recent study show enteric-coated aspirin cause minimal acute gastric injury . The investigator postulate among patient without H. pylori infection history ulcer bleeding continue use low-dose aspirin , enteric-coated aspirin reduce long-term risk ulcer complication level comparable average-risk aspirin user .</brief_summary>
	<brief_title>Prevention Recurrent Ulcer Bleeding High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori</brief_title>
	<detailed_description>Low-dose aspirin increasingly use prophylaxis coronary heart disease stroke . However , also important cause peptic ulcer bleed worldwide . In England Wales , low-dose aspirin estimate account 10 % ulcer bleeding people age 60 [ Weil 1995 ] . The problem aspirin-related ulcer disease expand increase use aspirin cardiovascular prophylaxis . No dose aspirin entirely free risk . Using daily dose aspirin low 75 mg , risk ulcer bleed double non-users [ Weil 1995 ] . Previous ulcer disease concurrent major medical illness important risk factor ulcer bleed low-dose aspirin . Among aspirin user , previous ulcer disease 5-fold increase risk ulcer bleed [ Lanas 2000 ] . Various strategy use prevent recurrent ulcer bleed high-risk aspirin user , eradication Helicobacter pylorus , use prophylactic anti-ulcer drug enteric-coated aspirin . Recently , investigator show eradication H. pylorus comparable maintenance treatment omeprazole , potent acid suppressant , prevent recurrent ulcer bleed high-risk aspirin user [ Chan 2001 ] . However , 50 % aspirin user infect H. pylorus . The optimal strategy prevent ulcer complication high-risk aspirin user infect H. pylorus remain undefined . Although co-therapy aspirin acid suppressant reduces risk ulcer bleeding , drug compliance may limit clinical usefulness particularly patient already receive multiple drug . References Weil J , Colin-Jones D , Langman M , et al . Prophylactic aspirin risk peptic ulcer bleeding . Br Med J 1005 ; 310:827-30 . Lanas A , Bajador E , Serrano P , et al . Nitrovasodilators , low-dose aspirin , nonsteroidal antiinflammatory drug , risk upper gastrointestinal bleeding . N Engl J Med 2000 ; 343:834-9 . Chan FKL , Chung SCS , Suen BY , et al . Preventing recurrent upper gastrointestinal bleeding patient Helicobacter pylori infection take low-dose aspirin naproxen . N Engl J Med 2001 ; 344:967-73 .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>High risk cohort : 1 . History endoscopically confirm ulcer bleeding 2 . Need longterm aspirin cardiovascular cerebrovascular prophylaxis 3 . A negative test H. pylorus base histology 1 . Concomitant use antiulcer drug , anticoagulant , nonaspirin NSAIDs steroids 2 . Current past H. pylorus infection 3 . Previous acidreduction gastric surgery 4 . Gastric outlet obstruction , erosive esophagitis , gastroesophageal varix 5 . Moribund incurable cancer Averagerisk cohort Inclusion criterion : Patients must fulfill ALL follow : 1 . No history ulcer bleed 2 . Need longterm aspirin cardiovascular cerebrovascular prophylaxis 3 . H. pylori positive OR negative Exclusion criterion : 1 . Concomitant use antiulcer drug , anticoagulant , nonaspirin NSAIDs steroid 2 . Previous acidreduction gastric surgery 3 . Moribund incurable cancer 4 . Previous attempt H. pylorus eradication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>